US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.6093
  • +0.0093+1.55%
Close Feb 14 16:00 ET
  • 0.5850
  • -0.0243-3.99%
Post 19:58 ET
3.10MMarket Cap-0.13P/E (TTM)

About Matinas BioPharma Company

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Company Profile

SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees32
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805
Websitehttp://www.matinasbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jerome D. Jabbour, J.D.
  • Chief Executive Officer, President and Director
  • --
  • Keith A. Kucinski, C.P.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Eric J. Ende, M.B.A.,M.D.
  • Chairman of the Board
  • --
  • Dr. Matthew A. Wikler, M.B.A.,M.D.
  • Independent Director
  • --
  • Natasha Giordano
  • Independent Director
  • --
  • Dr. Robin L. Smith, M.B.A.,M.D.
  • Independent Director
  • --
  • Evelyn D’An
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?